| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cardiff Oncology, Inc. | Former Director | Stock Options | 477,870 | $1,242,462 | $2.60 | 10 Jun 2021 | Direct |
| Hepion Pharmaceuticals, Inc. | Director | Stock Options | 291,050 | 18 May 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CRDF | Cardiff Oncology, Inc. | 10 Jun 2021 | 7 | $0 | 4 | Former Director | 14 Jun 2021, 16:10 |
| HEPA | Hepion Pharmaceuticals, Inc. | 18 May 2021 | 1 | $0 | 4 | Director | 20 May 2021, 16:33 |